Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing impurities.

More than 233,000 bottles of duloxetine capsules sold by Rising Pharmaceuticals were voluntarily recalled on Nov. 19, and the U.S. Food and Drug Administration assigned the recall as a class II ...

Newer evidence has suggested, however, that gabapentin may not work for all pain conditions and is associated with falls. As ...

In patients receiving serotonergic medications in combination with an ... The combined effects of duloxetine and MAOIs have not been evaluated in humans to date. It is recommended that duloxetine ...

Among 57,086 older adults, new gabapentin users demonstrated lower fall-related healthcare visits than duloxetine users, with ...

The prescription drug Cymbalta, generically duloxetine, is under recall for cancer-causing impurities that may have occurred naturally.

The U.S. Food and Drug Administration classified capsules of duloxetine, sold by New Jersey-based company Rising Pharmaceuticals, as a Class II risk on Dec. 5. The risk level is the FDA's second ...

and was set as a "class II" risk level by the FDA on Dec. 5. The medication was recalled due to the "presence of N-nitroso-duloxetine impurity above [the] recommended interim limit," the FDA said.

The Food and Drug Administration (FDA) has announced a significant recall affecting over 550,000 bottles of duloxetine delayed-release capsules. This recall comes as a result of elevated levels of ...

A nationwide recall of more than 233,000 bottles of duloxetine, an anti-depressant, has been announced by the Food and Drug Administration for possibly containing a chemical increasing the risk of ...

bottles of duloxetine have been recalled due to potentially containing high levels of cancer-causing impurities.

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...